Caloporoside derivatives, methods for the production thereof and their use

Details for Australian Patent Application No. 2002250998 (hide)

Owner Sanofi-Aventis Deutschland GmbH

Inventors Bronstrup, Mark; Toti, Luigi; Kurz, Michael; Eder, Claudia

Agent Watermark

Pub. Number AU-B-2002250998

PCT Pub. Number WO2002/072110

Priority 101 11 682.9 09.03.01 DE

Filing date 23 February 2002

Wipo publication date 24 September 2002

Acceptance publication date 23 March 2006

International Classifications

A61K 31/70 (2006.01) - Carbohydrates

A61P 35/00 (2006.01) Antineoplastic agents

C07H 13/06 (2006.01) Compounds containing saccharide radicals esterified by carbonic acid or derivatives thereof, or by organic acids, e.g. phosphonic acids

C07H 15/18 (2006.01) Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals

Event Publications

20 March 2003 Application Open to Public Inspection

  Published as AU-B-2002250998

22 December 2005 Assignment before Grant

  Aventis Pharma Deutschland GmbH The application has been assigned to Sanofi-Aventis Deutschland GmbH

23 March 2006 Application Accepted

  Published as AU-B-2002250998

20 July 2006 Standard Patent Sealed

20 September 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002250999-OPTICAL ELEMENT, WITH INTENSITY-DEPENDENT REFRACTION INDEX

2002250997-Use of thiolutin dioxide and its derivatives in the manufacture of a medicament for the treatment of CNS disorders and a process for the preparation thereof